Clinical Trial Update: [18F]FES PET/.CT in Uterine Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating [18F]FES PET/CT imaging for uterine cancer is currently recruiting at the Abramson Cancer Center (Penn Medicine).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Cancer

Drugs mentioned

• [18F]FES PET/CT (fluoroestradiol PET/CT imaging agent)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Uterine Cancer | Phase 2 | Status: RECRUITING